Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy

AIM: To evaluate the effects of panretinal photocoagulation (PRP) compared with PRP plus intravitreal bevacizumab (IVB) in patients with high-risk proliferative diabetic retinopathy (PDR) according to the Early Treatment Diabetic Retinopathy Study criteria. METHODS: The data were collected retrospec...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Ophthalmol
Main Authors: Zhou, Ai-Yi, Zhou, Chen-Jing, Yao, Jing, Quan, Yan-Long, Ren, Bai-Chao, Wang, Jian-Ming
Format: Artigo
Jezik:Inglês
Izdano: International Journal of Ophthalmology Press 2016
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154991/
https://ncbi.nlm.nih.gov/pubmed/28003978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2016.12.12
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki